BMY - Zai Lab reports Krazati lung cancer study meets primary endpoint
2024-04-01 10:57:29 ET
More on Bristol-Myers Squibb Company , Zai Lab, etc.
- Bristol Myers Squibb: The Comeback Is Unfolding
- Bristol-Myers Squibb Is Not A Buy For Me
- Bristol-Myers Squibb Company (BMY) Barclays 26th Annual Global Healthcare Conference (Transcript)
- Bristol Myers drug Zeposia fails Phase 3 study for Crohn's disease
- Novocure climbs after late-stage win for lung cancer therapy